Xenon-VR Announces Name Change to Xenon Ophthalmics™ and Patents Granted
December 19, 2022 – Belleville, NJ USA – Xenon-VR, Inc. of Belleville, New Jersey, USA, has officially changed its company name to Xenon Ophthalmics™ Inc. Zeshan Khan, President, Founder, and CEO of the company, states, “The new name reflects our industry emphasis and expertise. It also capitalizes on our shift away from VR as our primary […]
New Tech Partnership to Deliver ‘Next Gen’ Diagnostic
ORLANDO – Xenon-VR showcased the Xenon-1, a mobile virtual reality unit designed to perform multiple diagnostic procedures for the eye, here at Vision Expo East. Xenon chairman and founder Zeshan Khan told Healio that the platform comprises a headset with two modules, a tablet, and the software. Module 1 is used to perform multiple visual […]
Xenon-VR Intros VR Device Vision Diagnostics
Product: Xenon-1 Top Line: Xenon-VR Inc., based in Belleville, N.J., is launching the Xenon-1, a novel medical grade patented mobile virtual reality headset which will transform visual field assessment for both the doctor and the patient. This unique headset contains liquid lens technology which can be customized to each patient’s refractive error. Close Up: According to practicing optometrist, Robert […]
Xenon Introduces VR Device for Vision Diagnostics
ORLANDO – Xenon-VR showcased the Xenon-1, a mobile virtual reality unit designed to perform multiple diagnostic procedures for the eye, here at Vision Expo East. Xenon chairman and founder Zeshan Khan told Healio that the platform comprises a headset with two modules, a tablet, and the software. Module 1 is used to perform multiple visual […]
Xenon-VR Inc. Introduces Ophthalmic Diagnostic Device
Xenon-VR Inc. announced the Xenon-1, a novel medical grade patented mobile virtual reality headset which will transform visual field assessment for both the doctor and the patient. This unique headset contains liquid lens technology which can be customized to each patient’s refractive error. According to practicing optometrist, Dr. Robert Gilligan, a major advantage of the […]